Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity

Environmental Health Perspectives

Volumn 107, Issue SUPPL. 5, 1999, Pages 807-810

  Bagenstose, Lee M ^a   Salgame, Padmini ^a   Monestier, Marc ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Cytokines; Mercury; Rodent models; T cells

Indexed keywords

AUTOANTIBODY; CYTOKINE; MERCURIC CHLORIDE;

ANIMAL CELL; ANIMAL MODEL; AUTOIMMUNE DISEASE; CONFERENCE PAPER; GENE EXPRESSION; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALIA; RODENTIA;

EID: 0032750686     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107s5807     Document Type: Conference Paper

References (62)

1. Rosen A, Casciola-Rosen L. Environmental determinants of autoimmune disease., The Autoimmune Diseases (Rose NR, Mackay IR, eds). San Diego:Academic Press, 1998;119-126.
2. Goldman M, Druet P, Gleichmann E. ThH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 12:223-227 (1991).
3. Pelletier L, Castedo M, Bellon B, Druet P. Mercury and autoimmunity. In: Immunotoxicology and Immunopharmacology (Dean JH, Luster MI, Munson AE, Kimber I, eds). New York:Raven Press, 1994;539-552.
4. Monestier M. Nucleolar autoantibodies. In: Autoantibodies Peter JB, Shoenfeld Y. eds). Amsterdam:Elsevier, 1996;567-573.
5. Mathieson PW. Mercuric chloride-induced autoimmunity. Autoimmunity 13:243-247 (1992).
6. Druel P, Teychenne P, Mandet C, Bascou C, Druet E. Immune-type glomerulonephritis induced in the Brown-Norway rat with mercury-containing pharmaceutical products. Nephron 28:145-1481 (1981).
7. Hultman P, Enestrom S. Dose-response studies in murine mercury-induced autoimmunity and immune-complex disease. Toxicol Appl Pharmacol 113:199-208 (1992).
8. Pusey, CD Bowman C, Morgan A, Weetman AP, Hartley B, Lockwood CM. Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the Brown Norway rat. Clin Exp Immunol 81:76-82 (1990).
9. 2-induced membranous glomerulopathy. Am J Pathol 146:1467-1480 (1995).
10. Hultman P, Enestrom S, Pollard KM, Tan EM. Anti-fibrillarin antibodies in mercury-treated mice. Clin Exp Immunol 78:470-477 (1989).
11. Reuter R, Tessars G, Vohr HW, Gleichmann E, Luhrmann R. Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. Proc Natl Acad Sci USA 86:237-241 (1989).
12. S mice. J Immunol 152:667-675 (1994).
13. Castedo M, Pelletier L, Pasquier R, Druet P. Improvement of TH1 functions during the regulation phase of mercury disease in brown Norway rats. Scand J Immunol 39:144-150 (1994).
14. Bridoux F, Badou A, Saoudi A, Bernard I, Druet E, Pasquier R, Druet P, Pelletier L. Transforming growth factor β (TGF-β)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J Exp Med 185:1769-1775 (1997).
15. 2-induced autoimmunity in haplotype-heterozygous mice is an intrinsic property of B cells. J Immunol 161:1778-1785 (1998).
16. 2-treated mice. Clin Immunol Immunopathol 84:328-337 (1997).
17. Aten J, Veninga A, de Heer E, Rozing J, Nieuwenhuis P, Hoedemaeker PJ, Weening JJ. Susceptibility to the induction of either autoimmunity or immunosuppression by mercuric chloride is related to the major histocompatibility complex class II haplotype. Eur J Immunol 21:611-616 (1991).
18. Hultman P, Turley SJ, Enestrom S, Lindh U, Pollard KM. Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity. J Autoimmunity 9:139-146 (1996).
19. Goter Robinson CJ, White HJ, Rose NR. Murine strain differences in response to mercuric chloride: antinucleolar antibodies production does not correlate with renal immune complex deposition. Clin Immunol Immunopathol 83:127-138 (1997).
20. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539-542 (1992)
21. Gajewski TF, Schell SR, Fitch FW. Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J Immunol 144:4110-4120 (1990).
22. Weavar CT, Hawrylowicz CM, Unanue ER. T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc Natl Acad Sci USA 85:8181-8185 (1988).
23. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12:635-673 (1994).
24. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK. IL-12-deficient mice are defective in IFN γ production and Type 1 cytokine responses. Immunity 4:471-481 (1996)
25. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okamura H, Nakanishi K, Akira S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383-390 (1998).
26. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFκ B. Immunity 7:571-581 (1997).
27. H1 cells, Immunol Today 14:335-33 (1993).
28. Mosmann TR, Coffman R. Differing patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173 (1989).
29. Gillespie KM, Saoudi A, Kuhn J, Whittle CJ, Druet P, Bellon B, Mathieson PW. Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains. Eur J Immunol 26:2388-2392 (1996).
30. Mathieson PW, Gillespie KM. Cloning of a partial cDNA for rat interleukin-12 (IL-12) and analysis of IL-12 expression in vivo. Scand J Immunol 44:11-14 (1996)
31. Van der Meide PH, de Labie MC, Botman CA, Aten J, Weening JJ, Nitric oxide suppresses IFN-γ production in the spleen of mercuric chloride-exposed brown Norway rats. Cell Immunol 161:195-206 (1995).
32. Prigent P, Saoudi A, Pannetier C, Graber P, Bonnefoy J-Y, Druet P, Hirsch F. Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in Brown Norway rats, directly triggers T cells to produce interleukin-4. J Clin Invest 96:1484-1489 (1995).
33. Oliveira DB, Gillespie K, Wolfreys K, Mathieson PW, Qasim F, Coleman JW. Compounds that induce autoimmunity in the Brown Norway rat sensitize mast cells for mediator release and interleukin-4 expression. Eur J Imnmnol 25:2259-2264 (1995).
34. van Vliet E, Uhrberg M, Stein C, Gleichmann E. MHC control of IL-4-dependent enhancement of B cell la expression and Ig class switching in mice treated with mercuric chloride. Int Arch Allergy Immunol 101:392-401 (1993).
35. Johansson U, Sander B, Hultman P. Effects of the murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity. J Autoimmunity 10:347-355 (1997).
36. Hu H, Abedi-Valugerdi M, Moller G. Pretreatment of lymphocytes with mercury in vitro induces a response in T cells from genetically determined low-responders and a shift of the interleukin profile Immunology 90:198-204 (1997).
37. 2 in the rat, its possible role in an experimental autoimmune disease. Eur J Immunol 12:620-625 (1982).
38. 2 induces T and B cells to proliferate and differentiate in BN rats. Clin Exp Immunol 71:336-342 (1988).
39. Ochel M, Vohr HW, Pfeiffer C, Gleichmann E. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol 146:3006-3011 (1991).
40. d mice is mediated by interferon-γ (IFN-γ) Clin Exp lmmunol 109:149-156 (1997).
41. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune disease in NOD mice. J Exp Med 181:817-821 (1995).
42. Lamont AG, Adorini L. IL-12, a key cytokine in immune regulation. Immunol Today 17:216-219(1996).
43. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK, Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177:1505-1509 (1993).
44. Sypek JP, Chung CL, Mayor SEH, Subramanyam JA, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 response. J Exp Med 177:1797-1802 (1993).
45. Bagenstose LM, Salgame P, Monestier M. IL-12 down regulates autoantibody production in mercury-induced autoimmunity. J Immunol 160:1612-1617 (1998).
46. Germann T, Guckes S, Bongartz M, Diugonska H, Schmitt E, Kolbe L, Kolsch E, Podlaski FJ, Gately MK, Rude E. Administration of IL-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgE. Int Immunol 7:1649-1657 (1995)
47. Kono DH, Balomenos D, Pearson DL, Park MS, Hildebrandt B, Hultman P, Pollard KM. The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-γ and not Th1/Th2 imbalance. J Immunol 161:234-240 (1998).
48. Bagenstose LM, Salgame P, Monestier M. Mercury-induced autoimmunity in the absence of interleukin-4. Clin Exp Immunol 1149-121 (1998).
49. Enestrom S, Hultman P. Does amalgam affect the immune system? A controversial issue. Int Arch Allergy Immunol 106:180-203 (1995).
50. ++ induce cellular cytotoxicity and interferon production in mufine T lymphocytes. Immunobiology 175:455 (1987).
51. Saoudi A, Castedo M, Nochy D, Mandet C, Pasquier R, Druet P, Pelletier L. Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polycolonal activation and transfer autoimmunity in CDB-depleted normal syngeneic recipients. Eur J Immunol 25:1972-1979 (1995).
52. Kubicka-Muranyi M, Griem P, Lubben B, Rottmann N, Luhrmann R, Gleichmann E. Mercuric-chloride-induced autoimmunity in mice involves up-regulated presentation by spleen cells of altered and unaltered nucleolar self antigen. Int Arch Allergy Immunol 108:1-10 (1995).
53. Kubicka-Muranyi M, Kremer J, Rottmann N, Lubben B, Albers R, Bloksma N, Luhrmann R, Gleichmann E. Murine systemic autoimmune disease induced by mercuric chloride. T helper cells reacting to self-proteins. Int Arch Allergy Immunol 109:11-20 (1996)
54. 2-induced interleukin-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through L-type calcium channels J Biol Chem 272:32411-32418 (1997).
55. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 52:711-760 (1983).
56. Van der Meide PH, de Labie MC, Botman CA, van Bennekom WP, Olsson T, Aten J, Weening JJ. Mercuric chloride down-regulates T cell interferon-γ production in brown Norway but not in Lewis rats: role of glutathione. Eur J Immunol 23:675-681 (1993).
57. Jeannin P, Delneste Y, Lecoanet-Henchoz S, Gauchat JF, Life P, Holmes D, Bonnefoy JY. Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis. J Exp Med 182:1785-1792 (1995).
58. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Tf1 versus Th2 response patterns. Proc Natl Acad Sci USA 95:3071-3076 (1998).
59. 2-induced immune dysregulation. Biochem Biophys Res Commun 240:452-457 (1997).
60. Hu H, Moller G, Abedi-Valugerdi M. Thiol compounds inhibit mercury-induced immunological and immunopathological alterations in susceptible mice. Clin Exp Immunol 107:68-75 (1997).
61. Griem P, Gleichmann E. Metal ion induced autoimmunity. Current Opinion Immunol 7:831-838 (1995).
62. Pollard KM, Lee DK, Casiano CA, Bluthner M, Johnston MM, Tan EM. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol 158:3521-3528 (1997).